Comments

Pluri

Q: What sector and industry does Pluri (PLUR) operate in?

Pluri is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PLURNASDAQ

Perks Buy Compare Brokers

$5.45

-0.25-4.39%

At Close: -

$5.75

0.35.50%

After Hours: Jul 18, 9:09 AM EDT

15 minutes delayed

Pluri (PLUR) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Pluri (NASDAQ:PLUR) Stock Quotes, Forecast and News Summary

Pluri Stock (NASDAQ: PLUR) stock price, news, charts, stock research, profile.

Open	$5.48
Close	$5.45
Volume / Avg.	4.24K / 7.92K
Day Range	5.38 - 5.99
52 Wk Range	3.45 - 8.48
Market Cap	$29.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	0.49%
Days to Cover	2.16

Recent News

Pluri Gets $4.2M Contract To Advance Development Of Treatment For Radiation Syndrome

Pluri Inc. (NASDAQ: PLUR) has signed a three-year, $4.2 million contract with the U.S.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Pluri Inc

Sector

Health Care

Industry

Biotechnology

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pluri (PLUR) stock?

You can purchase shares of Pluri (NASDAQ:PLUR) through any online brokerage.

View our list of the best stock brokerages

Who are Pluri (PLUR) competitors?

Other companies in Pluri’s space includes: NKGen Biotech (NASDAQ:NKGN), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Nanoviricides (AMEX:NNVC) and Bolt Biotherapeutics (NASDAQ:BOLT).

What is the target price for Pluri (PLUR) stock?

There is no analysis for Pluri.

What is the forecast for Pluri (PLUR) stock?

There is no analysis for Pluri to provide a consensus price target.

Current stock price for Pluri (PLUR)?

The stock price for Pluri (NASDAQ: PLUR) is $5.75 last updated July 18, 2024 at 9:09 AM EDT.

Does Pluri (PLUR) pay a dividend?

There are no upcoming dividends for Pluri.

When is Pluri (NASDAQ:PLUR) reporting earnings?

Pluri’s Q4 earnings are confirmed for Tuesday, September 10, 2024.

Is Pluri (PLUR) going to split?

There is no upcoming split for Pluri.

What sector and industry does Pluri (PLUR) operate in?

Pluri is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-